drugset / Trial / NCT04792021
Effect of N-acetylcysteine on Oxidative Stress in COVID-19 Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of the study is to assess the potential therapeutic effect of N-acetylcysteine "NAC" in COVID 19 patients.
Timeline
- Start
- 2021-03-09
- Primary completion
- 2021-09-13
- Completion
- 2022-04-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | N-acetylcysteine | Small molecule | 600 mg | Oral |